Blood pressure parameters and cognitive decline and dementia after stroke or transient ischemic attack: results from the PROGRESS trial
American Journal of Hypertension · 01.09.2026 · 39 (9) · 1151-1159
DOI: 10.1093/ajh/hpag056 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift American Journal of Hypertension, online erschienen am 19.06.2026. Verfasst von Sultana Shajahan und 9 weiteren Autor:innen. Beteiligte Einrichtung: The George Institute for Global Health, The University of New South Wales, Sydney, Australia. Hauptthemen laut MEDLINE: Dementia, Stroke, Cognitive Dysfunction, Ischemic Attack, Transient. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research Council of New Zealand, Australian National Health and Medical Research Council, University of New South Wales.
Themen: Demenz, Schlaganfall
Abstract (Originalsprache)
Background
Besides elevated mean systolic blood pressure (BP), BP variability, pulse pressure (PP), or mean arterial pressure (MAP) could be important targets for dementia prevention. This study investigated these associations in participants with stroke or transient ischemic attack from the Perindopril Protection Against Recurrent Stroke Study (PROGRESS) trial.
Methods
BP parameters were calculated from measurements for 18 months on six occasions. Risk of cognitive decline according to Mini-Mental State Examination scores and/or adjudicated dementia outcomes per 1-standard deviation higher for each BP parameter was calculated using modified Poisson regression models with a log link. Subgroup analysis was conducted by mild cognitive impairment (MCI) at baseline, sex, and stroke subtype.
Results
Of 5128 participants recruited between May 1995 and November 1997, 567 (11.1%) developed cognitive decline/dementia after 4 (median) years of follow-up until 2001. For systolic BP (SBP), higher mean, maximum, cumulative load, and last measure were associated with higher risk of cognitive decline/dementia, but mean conferred the highest risk (relative risk 1.18, 95% confidence intervals [CIs] 1.06-1.31). For diastolic BP, higher mean, maximum, variability, cumulative load, slope, and last measure were associated, while load showed the strongest association (1.23, 95% CI 1.12-1.36). Only the mean PP was associated (1.11, 95% CI 1.00-1.24). For MAP, MAP load showed the strongest association (1.20, 95% CI 1.09-1.33). Systolic, diastolic, and MAP variability showed a higher risk in those without MCI.
Conclusions
Besides mean SBP, higher variability, cumulative load, slope, and last measures of diastolic BP, PP, and MAP were associated with increased risk of cognitive decline/dementia. Clinical Trial Registration This trial was not registered because enrollment began before July 1, 2005.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The George Institute for Global Health, The University of New South Wales, Sydney, Australia.
- The George Institute for Global Health, Imperial College London, London, United Kingdom.
- Institute of Science and Technology for Brain-inspired Intelligence, Fudan University, Shanghai, China.
- Neurology Department, Royal Prince Alfred Hospital, Sydney, Australia.
- Prince of Wales Clinical School, The University of New South Wales, Sydney, Australia.
- Department of Health, Medicine, and Caring Sciences, Linköping University, Linköping, Sweden.
ORCID-Profile: Sultana Shajahan, Mark Woodward, Craig S Anderson, Cheryl Carcel, Linan Chen, Ruth Peters, Karin Rådholm, Stephen Harrap, John Chalmers, Katie Harris
Förderung
- Health Research Council of New Zealand
- Australian National Health and Medical Research Council
- University of New South Wales
- The George Institute for Global Health
- NHMRC
- MRF_
- AstraZeneca
- Heart Foundation Vanguard
Zitieren
APA
Shajahan, S., Woodward, M., Anderson, C. S., Carcel, C., Chen, L., Peters, R., Rådholm, K., Harrap, S., Chalmers, J., & Harris, K. (2026). Blood pressure parameters and cognitive decline and dementia after stroke or transient ischemic attack: results from the PROGRESS trial. American Journal of Hypertension, 39(9), 1151-1159. https://doi.org/10.1093/ajh/hpag056
Vancouver
Shajahan S, Woodward M, Anderson CS, Carcel C, Chen L, Peters R, et al. Blood pressure parameters and cognitive decline and dementia after stroke or transient ischemic attack: results from the PROGRESS trial. American Journal of Hypertension. 2026;39(9):1151-1159. doi:10.1093/ajh/hpag056
BibTeX
@article{Shajahan2026,
author = {Shajahan, Sultana and Woodward, Mark and Anderson, Craig S and Carcel, Cheryl and Chen, Linan and Peters, Ruth and Rådholm, Karin and Harrap, Stephen and Chalmers, John and Harris, Katie},
title = {Blood pressure parameters and cognitive decline and dementia after stroke or transient ischemic attack: results from the PROGRESS trial},
journal = {American Journal of Hypertension},
year = {2026},
volume = {39},
number = {9},
pages = {1151--1159},
doi = {10.1093/ajh/hpag056}
}
EUVIMED